“Efficacy and Safety of Biosimilar Cetuximab (CETUXA) in Locoregionally Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck: A Retrospective Multicenter Analysis.”. Journal of Carcinogenesis, vol. 24, no. 10s, Dec. 2025, pp. 382-9, https://doi.org/10.64149/J.Carcinog.24.10s.382-389.